| Authors: |
Mainou M; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: mfcmary@hotmail.com., Tsapa K; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Michailidis T; First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, Greece., Malandris K; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Karagiannis T; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Avgerinos I; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Liakos A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Papaioannou M; Hematology Unit, First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, Greece., Terpos E; National and Kapodistrian University of Athens - Faculty of Medicine, Department of Clinical Therapeutics, Plasma Cell Dyscrasias Unit, Alexandra General Hospital, Athens, Greece., Prasad V; University of California San Francisco, Department of Epidemiology and Biostatistics, San Francisco, CA, USA., Tsapas A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece; Harris Manchester College, University of Oxford, Oxford, UK. |
